Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

David J. Sas; Peter C. Harris; Dawn S. Milliner

doi:10.1007/s00240-019-01166-6

Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

David J. Sas, Peter C. Harris, Dawn S. Milliner

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

Original language	English (US)
Journal	Urolithiasis
DOIs	https://doi.org/10.1007/s00240-019-01166-6
State	Accepted/In press - Jan 1 2019

Fingerprint

ASJC Scopus subject areas

Urology

Cite this

Sas, D. J., Harris, P. C., & Milliner, D. S. (Accepted/In press). Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3). Urolithiasis. https://doi.org/10.1007/s00240-019-01166-6

@article{e2492e5d764a48a2b69d713130074e30,

title = "Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)",

abstract = "The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.",

author = "Sas, {David J.} and Harris, {Peter C.} and Milliner, {Dawn S.}",

year = "2019",

month = jan,

day = "1",

doi = "10.1007/s00240-019-01166-6",

language = "English (US)",

journal = "Urolithiasis",

issn = "2194-7228",

publisher = "Springer Verlag",

}

TY - JOUR

T1 - Correction to

T2 - Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

AU - Sas, David J.

AU - Harris, Peter C.

AU - Milliner, Dawn S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

AB - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

UR - http://www.scopus.com/inward/record.url?scp=85074053468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074053468&partnerID=8YFLogxK

U2 - 10.1007/s00240-019-01166-6

DO - 10.1007/s00240-019-01166-6

M3 - Comment/debate

C2 - 31606780

AN - SCOPUS:85074053468

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

ER -

Access to Document

10.1007/s00240-019-01166-6